The purpose of this NIH-funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This trial involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
- All visits to be completed within a three-month period.
Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All participants must be diagnosed with type 2 DM and not be on any type of insulin therapy.
Please contact Alaaeldin Hodhod at